PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Heart attack survivors paint a complex picture of adhering to medicine

2014-01-13
(Press-News.org) Contact information: Thania Benios
thania_benios@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
Heart attack survivors paint a complex picture of adhering to medicine

Heart attack survivors of different races and genders are about equally likely to be on medications that reduce the risk of another heart attack and other potentially life-threatening cardiovascular problems. But according to a new study at the University of North Carolina at Chapel Hill, that's not the case a year later. The odds that an patient is still taking the medications as prescribed within a year vary significantly depending on race and gender, and black and Hispanic women are the least likely to adhere to their regimens.

The work, led by Gang Fang at the UNC Eshelman School of Pharmacy, suggest that while national initiatives have been effective in encouraging clinicians to prescribe preventive medications for heart-attack patients at the time of discharge, more needs to be done to help patients stay on those medications.

Fang and his team examined prescription records and looked at three types of medications—statins, beta blockers and ACEIs/ARBs— for more than 85,000 Medicare Part D beneficiaries who were hospitalized for a heart attack in 2008 and survived at least 30 days after discharge. The results, published last month in the journal Circulation, show that although there is little racial and gender disparity in getting the patients started on preventive medications, keeping them on those medications long-term is a different story.

"Adherence is a two-dimensional behavior: The physician has to prescribe the medication, and the patient has to fill the prescription," said Fang, an assistant professor in the School's Division of Pharmaceutical Outcomes and Policy.

"The policy implication from our study is that we should now put a lot of emphasis on helping patients, especially minority groups, understand the importance of these medications and help them improve their long-term adherence to get the greatest benefits."

Julie Lauffenburger, a graduate student at the school and first author on the paper, said the findings also point to a need for different interventions for different groups.

"Some adherence interventions in the past have focused on a blanket approach to emphasizing adherence even though patient demographic subgroups may have different needs and perceptions about medication use," she said. "These results suggest that more targeted interventions need to be considered, especially for adherence after heart attacks."

Using white men as the reference group for comparisons, the study found adherence was worse among racial minorities.



Black and Hispanic women were the least likely to be filling their prescriptions as prescribed in the year after discharge,

black and Hispanic patients had the lowest likelihood of adherence to beta-blockers and statins,

black patients had the lowest likelihood of adherence to ACEIs/ARBs

The study also found that women, who have worse outcomes than men after heart attacks, had worse adherence within each race group, especially in blacks and Hispanics. One possible explanation is a difference in men and women's beliefs on the severity of their heart attacks and the benefits from the medications.

The findings raise a number of other questions about what might influence adherence. For example, the study revealed different levels of adherence to each of the three medications within a race and gender group. White women, for instance, were more adherent to statins but less adherent to ACEIs/ARBs and beta-blockers.

"There is no clinical evidence that says one of these drugs is more important than the others," said Fang. "So this brings up a very interesting question about how clinicians and patients perceive benefits from each of the drugs."

The researchers also adjusted their results to control for out-of-pocket medication costs and whether the patients had a follow-up visit with a primary-care physician or a cardiologist. They did not find a significant connection between those factors and the racial and gender gaps in adherence.

"It's not just how much you pay for medications or whether you visit a primary-care physician or cardiologist after discharge," said Fang. "For instance, it could be whom you see—the quality of the providers' care and services."



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Benefits of cognitive training can last 10 years in older adults

2014-01-13
Benefits of cognitive training can last 10 years in older adults INDIANAPOLIS -- Exercises meant to boost mental sharpness can benefit older adults as many as 10 years after they received the cognitive training, researchers said Monday. In a study published in the Journal ...

New discovery could stimulate plant growth and increase crop yields, researchers say

2014-01-13
New discovery could stimulate plant growth and increase crop yields, researchers say Scientists led by experts at Durham University have discovered a natural mechanism in plants that could stimulate their growth even under stress and potentially lead to ...

Researchers investigating how to make PET imaging even sweeter

2014-01-13
Researchers investigating how to make PET imaging even sweeter Mount Sinai Heart leads international research team testing new sugar-based tracer to help in the cardiovascular imaging hunt for inflamed high-risk, vulnerable ...

Enforcement and anti-poaching measures set to fail

2014-01-13
Enforcement and anti-poaching measures set to fail In a paper published in Conservation Letters, researchers from the University of Kent's Durrell Institute of Conservation and Ecology (DICE) argue that despite record levels of funding being invested in enforcement ...

Understanding secondary light emission by plasmonic nanostructures may improve medical imaging

2014-01-13
Understanding secondary light emission by plasmonic nanostructures may improve medical imaging "Plasmonic nanostructures are of great current interest as chemical sensors, in vivo imaging agents, and for photothermal therapeutics," explained ...

Bragging rights: MSU study shows that interventions help women's reluctance to discuss accomplishments

2014-01-13
Bragging rights: MSU study shows that interventions help women's reluctance to discuss accomplishments BOZEMAN, Mont. -- A study published by Jessi L. Smith, professor of psychology at Montana State University, and Meghan Huntoon, who was Smith's student at MSU ...

Study: Kidney cancer patients preserve kidney function with robot-assisted partial nephrectomy

2014-01-13
Study: Kidney cancer patients preserve kidney function with robot-assisted partial nephrectomy

Hang up or hold on?

2014-01-13
Hang up or hold on? Study helps call centers know when patience is running out Press "1" if you're tired of being on hold! Nobody likes to wait, but since customer service can't be packaged to sit on a shelf ready when we need it, ...

Immune system development linked to leukemia

2014-01-13
Immune system development linked to leukemia Our defenses against infection can be weaknesses in causing cancer Scientists have discovered a genetic signature that implicates a key mechanism in the immune system as a driving force for a type of ...

Research uncovers key difference between our bodies' fight against viruses and bacteria

2014-01-13
Research uncovers key difference between our bodies' fight against viruses and bacteria Scientists at The University of Nottingham have discovered a key difference in the biological mechanisms by which the immune system responds to viral and bacterial ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Heart attack survivors paint a complex picture of adhering to medicine